PVLA (PVLA) Earnings Call Analysis
Next earnings call: 2026-08-04
(Q2 2026)
— full calendar
Earnings Reports
-
PVLA Q1 2026: $230M Financing Extends Runway, Accelerates Rare Disease Launch Ambitions
May 07, 2026
-
Povella Therapeutics (PVLA) Q4 2025: $230M Raise Extends Runway Through First-Line Launch
March 31, 2026
-
Palvella (PVLA) Q3 2025: Pipeline Expands to Four Rare Disease Programs as Platform Strategy Accelerates
November 11, 2025
-
Palvela (PVLA) Q2 2025: SELVA Phase 3 Enrollment Exceeds Target by 25%, Setting Up Four Major Catalysts
August 15, 2025